Search
Search Constraints
You searched for: Author/Creator Sauter, MaxLimit your search
- Sauter, Max [remove] 6
- 616.994 2
- 616.99481 2
- Brain -- Cancer -- Periodicals 2
- Brain -- Tumors -- Periodicals 2
- Brain Neoplasms -- Periodicals 2
- Nervous system -- Cancer -- Periodicals 2
- 615.5 1
- 615.580724 1
- AUC area under the curve -- BLI bioluminescence imaging -- B-NHL B-cell non-Hodgkin lymphoma -- CHX-A″-DTPA N-[(R)-2-amino-3-(p-isothiocyanato-phenyl)propyl]-trans-(S, S)-cyclohexane-1, 2-diamine-N, N, N′, N″, N″-pentaacetic acid -- 64Cu copper-64 -- CYS cystatin C -- Db diabody -- FITC fluorescein isothiocyanate -- HE hematoxylin and eosin -- 124I iodine-124 -- IgG immunoglobulin G -- 111In indium-111 -- ITLC instant thin layer chromatography -- 177Lu lutetium-177 -- mAb monoclonal antibody -- MFImax maximum median fluorescence intensity -- MTD maximum tolerated dose -- NRG mice non-obese diabetic-recombination activating gene-1 (NOD-Rag1null) interleukin (IL)-2 receptor common gamma chain (IL2rγnull) null mice -- PAS periodic acid–Schiff -- PBS phosphate-buffered saline -- PEG polyethylene glycol -- RIC radioimmunoconjugate -- RIT radioimmunotherapy -- SATA N-succinimidyl S-acetylthioacetate -- scFv single-chain variable fragment -- SDS-PAGE sodium dodecyl sulfate polyacrylamide gel electrophoresis -- SEC size exclusion chromatography -- 90Y yttrium-90 -- %IA/g percentage of injected activity per gram tissue 1
- BH3-mimetics -- ERK inhibitor -- MAPK inhibitor -- pediatric low-grade glioma -- synergism 1